What do a hemoglobin (Hgb) of 12.4 g/dL and a hematocrit (Hct) of 37.3% indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hemoglobin 12.4 g/dL and Hematocrit 37.3%: Clinical Interpretation

These values indicate mild anemia in adult males and postmenopausal females, but are within normal range for premenopausal females and prepubertal patients.

Normal Reference Ranges

The interpretation depends entirely on patient demographics:

For Adult Males and Postmenopausal Females

  • Anemia workup should be initiated when Hgb <12 g/dL (Hct <37%) 1
  • Your patient's values (Hgb 12.4, Hct 37.3%) are just above the threshold requiring investigation
  • These values represent approximately 80% of the mean normal level for this population 1

For Premenopausal Females and Prepubertal Patients

  • Anemia workup threshold is Hgb <11 g/dL (Hct <33%) 1
  • Your patient's values are clearly normal for this population
  • No further evaluation needed unless symptomatic

Clinical Significance

The Hgb/Hct relationship appears appropriate. The expected ratio is approximately 3:1 (Hct = Hgb × 3), and your values show 37.3/12.4 = 3.0, which is within normal limits 2, 3.

Key Clinical Considerations:

If this patient is an adult male or postmenopausal female:

  • These borderline-low values warrant clinical correlation with symptoms
  • Consider evaluation for underlying causes if symptomatic (fatigue, decreased exercise tolerance, cognitive changes)
  • In heart failure patients specifically, plasma hemoglobin levels lower than 90 g/L (9 g/dL) are associated with increased symptoms, but your patient is well above this threshold 4

If this patient has chronic kidney disease (CKD):

  • For CKD patients with heart failure and anemia, careful evaluation for underlying causes is recommended when Hgb <110 g/L (11 g/dL) or Hct <35% 4
  • Your patient's values (Hgb 12.4, Hct 37.3%) are above these thresholds and would not trigger anemia workup in CKD

If this patient has inflammatory bowel disease:

  • Anemia is defined as Hgb <13 g/dL for men and <12 g/dL for women 5
  • Your patient would be considered anemic if male, normal if female

Recommended Action Algorithm

  1. Determine patient sex and menopausal status

    • If premenopausal female or prepubertal: No action needed - values are normal
    • If adult male or postmenopausal female: Proceed to step 2
  2. Assess for symptoms of anemia

    • Fatigue, decreased exercise capacity, dyspnea, cognitive changes
    • If asymptomatic: Monitor, no immediate workup required
    • If symptomatic: Proceed to step 3
  3. Evaluate for underlying conditions

    • Check for chronic kidney disease (creatinine, eGFR)
    • Assess for heart failure
    • Screen for gastrointestinal blood loss
    • Evaluate iron status (ferritin, transferrin saturation) 6

Important Caveats

  • Hemoglobin is more accurate than hematocrit for assessing anemia because Hct is affected by sample storage time and hyperglycemia, while Hgb remains stable 1, 3
  • The commonly assumed 3:1 ratio (Hct = Hgb × 3) is age-dependent and not always accurate, particularly in children 2
  • In CKD patients on erythropoietin therapy, target ranges are Hgb 11-12 g/dL (Hct 33-36%), and your patient exceeds these targets 1

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.